Hospilux SA has announced the recruitment of Nicolas Henckes as Chief Executive Officer as of 1 January 2022 when he will take over from Claude Bindels who will remain the sole shareholder of the company and who will continue to act as a pharmacist for the company.
Nicolas Henckes, 46, a graduate of HEC Paris and former lawyer at the Paris Bar, has previously launched and successful developed the start-up Legitech sàrl and had a remarkable stint within Luxembourg employers' organisations as Director at the CLC.
“I always knew that one day I would take over a business leadership because it's in my DNA. Hospilux S.A. is a thriving company in a sector of the future, but very competitive and constantly evolving. The health sector, which I know well, is also a sector of high moral responsibility. I look forward to taking on this new challenge alongside a very professional and committed team" said Nicolas Henckes of his appointment.
For Claude Bindels, “Nicolas is an experienced entrepreneur and he is the ideal candidate to lead the company. We share the same values and that was an important point for me, after almost 25 years at the head of the company. He will be able to lead the digitistion and modernisation of the company while pursuing its commercial development so that it can face the challenges to come under the best possible conditions."
With its history of more than 35 years, Hospilux SA is today the national leader of specialised companies and distance selling companies in the field of medical needs and medical technology in Luxembourg, in both private and public health.
